• bitcoinBitcoin(BTC)$59,671.000.79%
  • ethereumEthereum(ETH)$1,591.752.16%
  • tetherTether(USDT)$1.000.01%
  • binancecoinBNB(BNB)$555.301.15%
  • usd-coinUSDC(USDC)$1.00-0.01%
  • rippleXRP(XRP)$1.050.83%
  • solanaSolana(SOL)$74.204.73%
  • tronTRON(TRX)$0.319734-0.55%
  • Figure HelocFigure Heloc(FIGR_HELOC)$1.052.60%
  • HyperliquidHyperliquid(HYPE)$65.837.94%
  • dogecoinDogecoin(DOGE)$0.072516-0.15%
  • RainRain(RAIN)$0.0159362.52%
  • USDSUSDS(USDS)$1.000.01%
  • leo-tokenLEO Token(LEO)$9.541.24%
  • zcashZcash(ZEC)$400.877.45%
  • stellarStellar(XLM)$0.1736921.63%
  • moneroMonero(XMR)$313.151.34%
  • CantonCanton(CC)$0.143949-3.09%
  • whitebitWhiteBIT Coin(WBT)$47.440.22%
  • chainlinkChainlink(LINK)$7.321.31%
  • cardanoCardano(ADA)$0.1443921.20%
  • USD1USD1(USD1)$1.00-0.02%
  • daiDai(DAI)$1.00-0.03%
  • LABLAB(LAB)$14.80-3.87%
  • Ethena USDeEthena USDe(USDE)$1.000.01%
  • the-open-networkGram (prev. Toncoin)(GRAM)$1.590.84%
  • bitcoin-cashBitcoin Cash(BCH)$199.165.14%
  • litecoinLitecoin(LTC)$42.790.53%
  • Circle USYCCircle USYC(USYC)$1.130.05%
  • hedera-hashgraphHedera(HBAR)$0.0712260.08%
  • Global DollarGlobal Dollar(USDG)$1.00-0.04%
  • avalanche-2Avalanche(AVAX)$6.622.82%
  • suiSui(SUI)$0.692.22%
  • paypal-usdPayPal USD(PYUSD)$1.00-0.05%
  • crypto-com-chainCronos(CRO)$0.0542050.64%
  • shiba-inuShiba Inu(SHIB)$0.0000042.14%
  • tether-goldTether Gold(XAUT)$3,987.59-1.52%
  • nearNEAR Protocol(NEAR)$1.830.94%
  • BlackRock USD Institutional Digital Liquidity FundBlackRock USD Institutional Digital Liquidity Fund(BUIDL)$1.000.00%
  • Ondo US Dollar YieldOndo US Dollar Yield(USDY)$1.140.15%
  • BittensorBittensor(TAO)$206.490.72%
  • World Liberty FinancialWorld Liberty Financial(WLFI)$0.0593661.87%
  • pax-goldPAX Gold(PAXG)$3,988.63-1.62%
  • uniswapUniswap(UNI)$2.86-1.70%
  • okbOKB(OKB)$79.832.78%
  • AsterAster(ASTER)$0.620.31%
  • Ripple USDRipple USD(RLUSD)$1.00-0.04%
  • OndoOndo(ONDO)$0.3123141.90%
  • HTX DAOHTX DAO(HTX)$0.0000020.37%
  • worldcoin-wldWorldcoin(WLD)$0.410419-6.01%
TradePoint.io
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop
No Result
View All Result
TradePoint.io
No Result
View All Result

Drugmakers developing monthly weight loss drugs rather than weekly

June 29, 2026
in Market & News
Reading Time: 1 min read
A A
ShareShareShareShareShare



Pfizer and Amgen are developing monthly GLP-1 shots with the goal being to make weight loss drugs more convenient and easier to maintain. Injections made by Wegovy and Zepbound are taken weekly. NBC News’ Berkeley Lovelace, Jr. explains how users may benefit.

For more context and news coverage of the most important stories of our day, click here:

YOU MAY ALSO LIKE

Iran and Israel exchange first attacks since ceasefire

Knicks’ Karl-Anthony Towns asked about Trump’s attendance at NBA Finals Game 3

» Subscribe to NBC News:
» Subscribe to Here’s the Scoop podcast:
» NBC News App:
» Breaking News Alerts:
» Visit NBCNews.Com:
» Find NBC News on Facebook:
» Follow NBC News on Twitter:
» Follow NBC News on Instagram:

#Drug #Health #Healthcare

source

ShareTweetSendSharePin

Related Posts

Iran and Israel exchange first attacks since ceasefire
Market & News

Iran and Israel exchange first attacks since ceasefire

June 30, 2026
Knicks’ Karl-Anthony Towns asked about Trump’s attendance at NBA Finals Game 3
Market & News

Knicks’ Karl-Anthony Towns asked about Trump’s attendance at NBA Finals Game 3

June 30, 2026
New York Knicks return to Madison Square Garden for Game 3 with new security measures
Market & News

New York Knicks return to Madison Square Garden for Game 3 with new security measures

June 30, 2026
High winds send objects flying at a Brooklyn rooftop pool as swimmers rush to leave
Market & News

High winds send objects flying at a Brooklyn rooftop pool as swimmers rush to leave

June 29, 2026
Next Post
6.1-magnitude earthquake near Cuba felt across southern Florida

6.1-magnitude earthquake near Cuba felt across southern Florida

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search

No Result
View All Result
New York Times went from self-appointed #MeToo beacon to sympathetic portrayal of Epstein’s enablers: sources

New York Times went from self-appointed #MeToo beacon to sympathetic portrayal of Epstein’s enablers: sources

June 24, 2026
Can’t Decide To Spend 0?

Can’t Decide To Spend $400?

June 25, 2026
“How Can I Help You?” – Dave

“How Can I Help You?” – Dave

June 26, 2026

About

Learn more

Our Services

Legal

Privacy Policy

Terms of Use

Bloggers

Learn more

Article Links

Contact

Advertise

Ask us anything

©2020- TradePoint.io - All rights reserved!

Tradepoint.io, being just a publishing and technology platform, is not a registered broker-dealer or investment adviser. So we do not provide investment advice. Rather, brokerage services are provided to clients of Tradepoint.io by independent SEC-registered broker-dealers and members of FINRA/SIPC. Every form of investing carries some risk and past performance is not a guarantee of future results. “Tradepoint.io“, “Instant Investing” and “My Trading Tools” are registered trademarks of Apperbuild, LLC.

This website is operated by Apperbuild, LLC. We have no link to any brokerage firm and we do not provide investment advice. Every information and resource we provide is solely for the education of our readers. © 2020 Apperbuild, LLC. All rights reserved.

No Result
View All Result
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop

© 2023 - TradePoint.io - All Rights Reserved!